Short Interest in Reckitt Benckiser Group plc (OTCMKTS:RBGLY) Declines By 98.7%

Reckitt Benckiser Group plc (OTCMKTS:RBGLY) saw a significant decline in short interest in the month of March. As of March 15th, there was short interest totalling 1,800 shares, a decline of 98.7% from the February 29th total of 141,600 shares. Based on an average daily volume of 3,144,000 shares, the short-interest ratio is currently 0.0 days.

Reckitt Benckiser Group Stock Up 2.0 %

OTCMKTS RBGLY traded up $0.22 on Thursday, hitting $11.37. 958,729 shares of the stock were exchanged, compared to its average volume of 940,548. Reckitt Benckiser Group has a fifty-two week low of $10.66 and a fifty-two week high of $16.60. The company has a 50-day moving average price of $13.56 and a 200-day moving average price of $13.76. The company has a current ratio of 0.54, a quick ratio of 0.36 and a debt-to-equity ratio of 0.57.

Reckitt Benckiser Group Increases Dividend

The firm also recently disclosed a dividend, which will be paid on Monday, June 3rd. Stockholders of record on Friday, April 12th will be issued a $0.2701 dividend. The ex-dividend date is Thursday, April 11th. This is an increase from Reckitt Benckiser Group’s previous dividend of $0.18.

Analyst Ratings Changes

A number of research analysts have weighed in on RBGLY shares. Jefferies Financial Group cut shares of Reckitt Benckiser Group from a “hold” rating to an “underperform” rating in a report on Monday, December 11th. BNP Paribas upgraded Reckitt Benckiser Group from an “underperform” rating to a “neutral” rating in a research report on Tuesday, January 9th. Finally, Sanford C. Bernstein upgraded Reckitt Benckiser Group from a “market perform” rating to an “outperform” rating in a research report on Monday, December 11th. One research analyst has rated the stock with a sell rating, four have issued a hold rating and one has issued a buy rating to the stock. Based on data from MarketBeat.com, the company presently has an average rating of “Hold” and an average price target of $6,978.00.

Reckitt Benckiser Group Company Profile

Reckitt Benckiser Group plc manufactures and sells health, hygiene, and nutrition products worldwide. It offers acne treatment creams, facial washes, and cleansing pads; germ protection products; condoms; heartburn and indigestion solutions; joints health products; chest congestion, cough, and sinus remedies; vaginal care routine products; sore throat medications; and hair removal products under the Clearasil, Dettol, Durex, Gaviscon, Nurofen, Mucinex, Queen V, Strepsils, and Veet brands.